J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sakai, N.
Right arrow Articles by Brewer, H. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sakai, N.
Right arrow Articles by Brewer, H. B., Jr
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 37, 2065-2073, Copyright © 1996 by Lipid Research, Inc.


ARTICLES

Exon 10 skipping caused by intron 10 splice donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection

N Sakai, S Santamarina-Fojo, S Yamashita, Y Matsuzawa and HB Brewer Jr
Molecular Disease Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1666, USA.

Cholesteryl ester transfer protein (CETP) deficiency is the most common cause of hyperalphalipoproteinemia in Japan. However, the genetic basis of this disorder has not been fully characterized. We have studied a 49- year-old Japanese male presenting with total cholesterol, HDL- cholesterol, and apolipoprotein A-I levels of 300, 236, and 233 mg/dl, respectively, and total absence of CETP activity and mass in plasma. Sequence analysis of the patient's CETP gene revealed that the splice donor consensus GT was substituted by GG in intron 10 (intron 10 splice defect) and by AT in intron 14 (intron 14 splice defect). Restriction digestion of PCR-amplified DNA using NdeI and MaeIII established that the patient was a compound heterozygote for both gene defects. Sequencing of cDNA amplified by RT-PCR from the patient's monocyte- derived macrophage RNA demonstrated abnormal splicing with deletion of exon 10 as well as alternative splicing at a native AG site located 31 nucleotides 5' of the normal splice acceptor in intron 13. Thus, the intron 10 splice defect results in exon 10 skipping and the insertion of a 31 bp fragment between exon 13 and exon 14, which contains an in frame stop codon. The presence of abnormally spliced mRNA was further confirmed by amplification of patient cDNA using CETP specific primers. Abnormal splicing of exon 14 as a result of the intron 14 splice defect was not detected, indicating potential unstable CETP mRNA derived from that mutation. These findings demonstrate that a novel splice site mutation in intron 10 of the CETP gene results in the skipping of exon 10, as well as disruption of downstream splicing at intron 13 identifying a novel mechanism leading to CETP deficiency.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
A J Brea-Fernandez, E Pomares, M J Brion, G Marfany, M J Blanco, M Sanchez-Salorio, R Gonzalez-Duarte, and A Carracedo
Novel splice donor site mutation in MERTK gene associated with retinitis pigmentosa
Br. J. Ophthalmol., October 1, 2008; 92(10): 1419 - 1423.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. E. Lira, A. K. Loomis, S. A. Paciga, D. B. Lloyd, and J. F. Thompson
Expression of CETP and of splice variants induces the same level of ER stress despite secretion efficiency differences
J. Lipid Res., September 1, 2008; 49(9): 1955 - 1962.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. M. Boekholdt and J. F. Thompson
Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease
J. Lipid Res., July 1, 2003; 44(6): 1080 - 1093.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Nagano, S. Yamashita, K.-i. Hirano, M. Ito, T. Maruyama, M. Ishihara, Y. Sagehashi, T. Oka, T. Kujiraoka, H. Hattori, et al.
Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader (R) assay
J. Lipid Res., July 1, 2002; 43(7): 1011 - 1018.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Nagano, S. Yamashita, K.-i. Hirano, T. Kujiraoka, M. Ito, Y. Sagehashi, H. Hattori, N. Nakajima, T. Maruyama, N. Sakai, et al.
Point Mutation (-69 G{->}A) in the Promoter Region of Cholesteryl Ester Transfer Protein Gene in Japanese Hyperalphalipoproteinemic Subjects
Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 985 - 990.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. W. Rittershaus, D. P. Miller, L. J. Thomas, M. D. Picard, C. M. Honan, C. D. Emmett, C. L. Pettey, H. Adari, R. A. Hammond, D. T. Beattie, et al.
Vaccine-Induced Antibodies Inhibit CETP Activity In Vivo and Reduce Aortic Lesions in a Rabbit Model of Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., September 1, 2000; 20(9): 2106 - 2112.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Dachet, O. Poirier, F. Cambien, J. Chapman, and M. Rouis
New Functional Promoter Polymorphism, CETP/-629, in Cholesteryl Ester Transfer Protein (CETP) Gene Related to CETP Mass and High Density Lipoprotein Cholesterol Levels : Role of Sp1/Sp3 in Transcriptional Regulation
Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 507 - 515.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. von Kodolitsch, R. E. Pyeritz, and P. K. Rogan
Splice-Site Mutations in Atherosclerosis Candidate Genes : Relating Individual Information to Phenotype
Circulation, August 17, 1999; 100(7): 693 - 699.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
W. H. Engfelt, K. R. Masuda, V. G. Paton, and S. K. Krisans
Splice donor site mutations in the 3-hydroxy-3-methylglutaryl coenzyme A reductase gene cause a deficiency of the endoplasmic reticulum 3-hydroxy-3-methylglutaryl coenzyme A reductase protein in UT2 cells
J. Lipid Res., November 1, 1998; 39(11): 2182 - 2191.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
C. Bruce, D. S. Sharp, and A. R. Tall
Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia
J. Lipid Res., May 1, 1998; 39(5): 1071 - 1078.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
E. M. Teh, P. J. Dolphin, W. C. Breckenridge, and M.-H. Tan
Human plasma CETP deficiency: identification of a novel mutation in exon 9 of the CETP gene in a Caucasian subject from North America
J. Lipid Res., February 1, 1998; 39(2): 442 - 456.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Ritsch, H. Drexel, F. W. Amann, C. Pfeifhofer, and J. R. Patsch
Deficiency of Cholesteryl Ester Transfer Protein : Description of the Molecular Defect and the Dissociation of Cholesteryl Ester and Triglyceride Transport in Plasma
Arterioscler. Thromb. Vasc. Biol., December 1, 1997; 17(12): 3433 - 3441.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.